Anixa Biosciences Announces Patent Issued for its Breast Cancer Vaccine

SAN JOSE, Calif., Nov. 5, 2019 /PRNewswire/ — Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body’s immune system in the

Read More